Canada became the first country in the world that has authorized the use of a plant-based COVID-19 vaccine. The two-dose vaccine of Medicago Inc. (a biopharma company owned by Mitsubishi Chemical and Philip Morris), can be given to adults who are aged between 18 to 64, but little data is available on the shots received by people aged 65 and above.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The decision to authorize the vaccine was based on a study conducted on 24,000 adults that showed the efficacy rate of the vaccine is 71% at preventing COVID-19 – although the tests were conducted before the omicron variant emerged. Covifenz is the name given to this vaccine. Canada agreed to buy 20 million doses of this plant-based vaccine, with an option to purchase 56 million additional doses.
Important takeaways for all competitive exams:
Retail inflation of India has increased slightly to 3.48% in April 2026 because of the…
The Indian Cyber Crime Coordination Centre has signed the MoU (Memorandum of Understanding) with the…
Moody's Ratings had downgrade the India's GDP forecast for the year 2026 amid certain reasons. This…
Respectable Supreme Court of India has taken the step towards the modernization of judicial services…
Respectable West Bengal Chief Minister Suvendu Adhikari has announced the Annapurna Bhandaar scheme across the…
To boost the manufacturing India is planning to launch the Made in India Brand Scheme…